Intravenous immunoglobulin therapy in kidney transplant recipients with de novo DSA: Results of an observational study

BACKGROUND: Approximately 25% of kidney transplant recipients develop de novo anti-HLA donor-specific antibodies (dnDSA) leading to acute antibody-mediated rejection (ABMR) in 30% of patients. Preemptive therapeutic strategies are not available. METHODS: We conducted a prospective observational stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Matignon, Marie, Pilon, Caroline, Commereuc, Morgane, Grondin, Cynthia, Leibler, Claire, Kofman, Tomek, Audard, Vincent, Cohen, José, Canoui-Poitrine, Florence, Grimbert, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487035/
https://www.ncbi.nlm.nih.gov/pubmed/28654684
http://dx.doi.org/10.1371/journal.pone.0178572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487035/
https://www.ncbi.nlm.nih.gov/pubmed/28654684
http://dx.doi.org/10.1371/journal.pone.0178572

Ejemplares similares